Clinical Trial: Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668895) titled 'Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis' on June 21.

Brief Summary: The goal of this clinical trial is to learn whether a study drug called Compound Betamethasone (also known as Diprospan) works to treat pulmonary sarcoidosis in people with early-stage disease (stage I or II). It will also learn about its safety compared to the standard treatment, prednisone.

The main questions it aims to answer are:

* How much does the study drug improve lung function (measured by a test called FVC%) after 24 weeks of treatment?

* How does it compare to prednisone in controlling symptoms, reducing...